# CareTrust REIT, Inc.: overview

CTRE · NYSE · CIK 1590717 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctre.md) · [Financials](/companies/ctre/financials.md) · [Filings](/companies/ctre/filings.md) · [Insiders](/companies/ctre/insiders.md)

Latest reported revenue: [$4.6m](/filings/0001628280-26-054284.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054284).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [77.4](/filings/0001628280-25-049531.md) | [(209) d](/filings/0001628280-26-007664.md) | [0.0](/filings/0001628280-26-032118.md) | [0.0](/filings/0001628280-26-054284.md) | [132](/filings/0001628280-25-049531.md) | [(340) d](/filings/0001628280-26-007664.md) | [3.9](/filings/0001628280-26-032118.md) | [4.6](/filings/0001628280-26-054284.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [43.2%](/filings/0001628280-25-049531.md) | [(24.9%) d](/filings/0001628280-26-007664.md) | not reported | not reported | [56.6%](/filings/0001628280-25-049531.md) | [(32.7%) d](/filings/0001628280-26-007664.md) | [2082.3%](/filings/0001628280-26-032118.md) | [1916.8%](/filings/0001628280-26-054284.md) |
| Diluted EPS | $ per share | [0.21](/filings/0001628280-25-049531.md) | not reported | [0.35](/filings/0001628280-26-032118.md) | [0.35](/filings/0001628280-26-054284.md) | [0.35](/filings/0001628280-25-049531.md) | not reported | [0.36](/filings/0001628280-26-032118.md) | [0.38](/filings/0001628280-26-054284.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001628280-23-002955.md) | [0.0](/filings/0001628280-23-002955.md) | [0.0](/filings/0001628280-26-007664.md) | [0.0](/filings/0001628280-26-007664.md) | [1,225](/filings/0001628280-26-007664.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | [26166.4%](/filings/0001628280-26-007664.md) |
| Diluted EPS | $ per share | [0.74](/filings/0001628280-24-003863.md) | [(0.08)](/filings/0001628280-25-005118.md) | [0.50](/filings/0001628280-26-007664.md) | [0.80](/filings/0001628280-26-007664.md) | [1.57](/filings/0001628280-26-007664.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ctre/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.64bn | 40,725,896 |  | Added +4,849,399 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $843.0m | 20,892,354 |  | Added +991,332 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $507.0m | 12,447,546 |  | Added +412,275 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $429.2m | 10,635,822 |  | Added +637,644 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $424.2m | 10,513,145 |  | Added +466,289 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $391.2m | 9,695,110 |  | Reduced −2,125,972 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $302.1m | 7,485,392 |  | Added +503,755 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $203.1m | 5,034,682 |  | Added +591,341 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $189.0m | 4,682,918 |  | Added +417,804 |
| [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $144.0m | 3,567,847 |  | Added +155,085 |

## Recent filings

[All 585 filings](/companies/ctre/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 21:12 ET | [8-K](/filings/0001628280-26-068370.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-068370 |
| 2026-10-02 | 06:00 ET | [8-K](/filings/0001628280-26-064352.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064352 |
| 2026-08-06 | 16:18 ET | [8-K](/filings/0001628280-26-054348.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-054348 |
| 2026-08-06 | 16:07 ET | [10-Q](/filings/0001628280-26-054284.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054284 |
| 2026-05-21 | 16:01 ET | [8-K](/filings/0001140361-26-022438.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-022438 |
| 2026-05-20 | 16:05 ET | [8-K](/filings/0001140361-26-022236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-022236 |
| 2026-05-07 | 16:18 ET | [8-K](/filings/0001628280-26-032150.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-032150 |
| 2026-05-07 | 16:14 ET | [10-Q](/filings/0001628280-26-032118.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032118 |
| 2026-04-30 | 16:06 ET | [8-K](/filings/0001628280-26-028864.md) | 5.07 Shareholder vote results | 0001628280-26-028864 |
| 2026-03-13 | 17:42 ET | [DEF 14A](/filings/0001628280-26-017386.md) | Proxy statement, period 2026-04-29 | 0001628280-26-017386 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-007664.md), filed Feb 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9986937b-1ad8-4816-9c1d-c1ce947e2916)

## About the filer

- CIK: 1590717
- Tickers: CTRE
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 06:14 ET. No prices; not investment advice.